Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Marinus Pharmaceuticals revenue
Marinus Pharmaceuticals's revenue is $31.0 million.
What is Marinus Pharmaceuticals's revenue?
- Marinus Pharmaceuticals's revenue growth from 2020 to 2023 is 1,703.78%.
- Marinus Pharmaceuticals has 113 employees, and the revenue per employee ratio is $274,238.
- Marinus Pharmaceuticals's peak quarterly revenue was $14.2M in 2022(q1).
- Marinus Pharmaceuticals peak revenue was $31.0M in 2023.
- Marinus Pharmaceuticals annual revenue for 2022 was 25.5M, 66.03% growth from 2021.
- Marinus Pharmaceuticals annual revenue for 2023 was 31.0M, 21.63% growth from 2022.
On this page
Zippi applies for you, and finds you a job.
Marinus Pharmaceuticals historical revenue
Marinus Pharmaceuticals's peak revenue was $31.0M in 2023. The peak quarterly revenue was $14.2M in 2022(q1).
Marinus Pharmaceuticals's revenue increased from $1.7m in 2020 to $31.0M currently. That's a 1,703.78% change in annual revenue.
Marinus Pharmaceuticals annual revenue
Marinus Pharmaceuticals annual revenue over time
| Fiscal year / year | Marinus Pharmaceuticals revenue |
|---|---|
| 2020 | $1.7M |
| 2021 | $15.3M |
| 2022 | $25.5M |
| 2023 | $31.0M |
How accurately did Marinus Pharmaceuticals' revenue projections match actual performance?
Marinus Pharmaceuticals annual growth
Marinus Pharmaceuticals saw the greatest revenue growth in 2021, when revenue increased by 793.19%.
Marinus Pharmaceuticals had the lowest revenue growth in 2022, when revenue changed by 66.03%.
Marinus Pharmaceuticals annual growth rate over time
| Year | Marinus Pharmaceuticals growth |
|---|---|
| 2021 | 793%↑ |
| 2022 | 66%↑ |
| 2023 | 22%↑ |
Marinus Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Marinus Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | - | - | $171,000 | $1.5M |
| 2021 | $1.8M | $1.9M | $10.1M | $1.5M |
| 2022 | $14.2M | $1.8M | $2.3M | $7.2M |
| 2023 | $10.4M | $6.1M | $7.3M | $7.2M |
| 2024 | $7.7M | $8.1M | $8.5M | - |
Marinus Pharmaceuticals jobs nearby
Do you work at Marinus Pharmaceuticals?
Is Marinus Pharmaceuticals transparent about its revenue structure?
Marinus Pharmaceuticals financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 113 |
| Date Founded | 2003 |
| Headquarters | Radnor, Pennsylvania |
| Number of Locations | 1 |
| Revenue | $31.0M |
| Net Income | -$19,816,000 |
| Gross Proft | $29.1M (2023) |
| PE Ratio | -1.27 |
| Tax Rate | 0.0% |
| Market Capitalization | $179.4M |
| Total Assets | $259,518,000 |
| Ticker | MRNS |
Marinus Pharmaceuticals jobs you might like
Marinus Pharmaceuticals financing
Marinus Pharmaceuticals received early financing of $29.4M on 2005-10-25.
| Series | Round size | Date |
|---|---|---|
| Series A | $29.4M | 10/2005 |
| Series B | $20M | 05/2009 |
| Series Unknown | $11.4M | 12/2012 |
| Series C | $21M | 01/2013 |
| Post Ipo Equity | $40.3M | 09/2017 |
| Post Ipo Equity | $70M | 12/2019 |
| Post Ipo Equity | $46M | 05/2020 |
| Post Ipo Debt | $45M | 05/2021 |
| Post Ipo Debt | $30M | 03/2022 |
| Post Ipo Equity | $1.2M | 04/2022 |
Marinus Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Canaan Partners | Series A |
| SOFINNOVA INVESTMENTS INC | Series A |
| Foundation Medical Partners | Series A |
| Domain Associates | Series A |
| Canaan Partners | Series B |
| SOFINNOVA INVESTMENTS INC | Series B |
| Foundation Medical Partners | Series B |
| Domain Associates | Series B |
| RMI Partners | Series Unknown |
| Canaan Partners | Series C |
| SOFINNOVA INVESTMENTS INC | Series C |
| Foundation Medical Partners | Series C |
| Domain Associates | Series C |
| Bain Capital Life Sciences | Post Ipo Equity |
| Bain Capital Life Sciences | Post Ipo Equity |
| Oaktree Capital Management | Post Ipo Debt |
| Oaktree Capital Management | Post Ipo Debt |
Marinus Pharmaceuticals competitors
Marinus Pharmaceuticals's top competitor, Impax Laboratories, earned an annual revenue of $775.8M.
Marinus Pharmaceuticals's smallest competitor is AcelRx Pharmaceuticals with revenue of $651.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Zogenix | - | $81.7M | 90 | - |
| Concert Pharmaceuticals | - | $32.6M | 71 | - |
| AcelRx Pharmaceuticals | - | $651,000 | 54 | - |
| Momenta Pharmaceuticals | - | $30.1M | 131 | - |
| Impax Laboratories | - | $775.8M | 1,257 | - |
| IPEC-Americas | - | $1.6M | 10 | - |
Marinus Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Marinus Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Marinus Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Marinus Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Marinus Pharmaceuticals. The data presented on this page does not represent the view of Marinus Pharmaceuticals and its employees or that of Zippia.
Marinus Pharmaceuticals may also be known as or be related to MARINUS PHARMACEUTICALS INC, Marinus Pharmaceuticals, Marinus Pharmaceuticals Inc and Marinus Pharmaceuticals, Inc.